- Fellowship - UT Southwestern Medical Center (2015-2016), Advanced Heart Failure & Transplant Cardiology
- Fellowship - UT Southwestern Medical Center (2012-2015), Cardiology
- Residency - University of California, San Francisco (2009-2012)
- Medical School - Brown University Medical School (2005-2009)
Sonia Garg, M.D.
Associate Medical Director of Cardiac Transplantation
- Internal Medicine - Cardiology
- Heart Failure & Cardiac Support
Sonia Garg, M.D., is an Assistant Professor of Cardiology in the Department of Internal Medicine at UT Southwestern. She is a member of the heart failure, heart transplant, and mechanical circulatory support teams.
Dr. Garg is originally from Michigan and received her undergraduate and graduate degrees from the Massachusetts Institute of Technology. She started her career in the computer industry working for the Microsoft Corporation. Drawn by her commitment to service, she left this line of work to earn her medical degree at Brown University.
Dr. Garg completed her residency at the University of California San Francisco Medical Center and performed fellowships in cardiovascular disease and advanced heart failure at UT Southwestern.
In addition to her clinical focus on the comprehensive care of heart failure patients, Dr. Garg’s research interests include cardiac remodeling, quality outcomes, and best practices in cardiac transplantation.
Meet Dr. Garg
Heart Failure and Transplantation Specialist in Dallas
As a cardiologist specializing in heart failure, heart transplant, and mechanical circulatory support, Sonia Garg, M.D., cares for patients at every stage of heart disease. She works with a multi-disciplinary team to ensure that patients are receiving the most comprehensive care possible.
Dr. Garg has a special focus on heart disease caused by rarer conditions such as amyloid, sarcoid, or myocarditis – and peripartum cardiomyopathy, a type of heart failure that occurs during pregnancy or soon after delivery.
“Heart failure isn’t always related to blockages in the arteries, or coronary artery disease. Often it’s related to something else, and it’s our job as a team to investigate those alternative causes so we can better tailor how to treat each patient,” Dr. Garg says.
No two patients – even those with similar diagnoses – are the same, so Dr. Garg makes sure she takes the time to talk through a patient’s health history.
“I always start from the beginning, even if the patient was diagnosed a long time ago. I ask ‘How and when did your symptoms begin; how have your symptoms progressed over time; and how is your disease impacting your daily activities?’ Sometimes these questions will take us back decades to try to understand where it all began,” she says.
A Team for Life
Dr. Garg recommends patients see her or one of her colleagues as soon after diagnosis as possible because early treatment can sometimes reverse or improve heart disease. She offers drug and device therapies and can also help patients who need a left ventricular assist device (LVAD) or even transplant.
If patients are at a stage where their disease is advanced enough to be irreversible and the limits of medical therapy have been reached, it’s her job, working in collaboration with other experts at UT Southwestern, to recognize when to go to the next step.
“We will see you through your journey to receiving an LVAD or transplant, and beyond,” she says. “You adopt us. We adopt you. We’re a team for life.”
- American College of Cardiology (2012), Member
- Heart Failure Society of America (2014), Member
- International Society for Heart and Lung Transplantation (2016), Member
- Alpha Omega Alpha 2009, Medical Honor Society
Redesigning the medical science curriculum at the Warren Alpert Medical School of Brown University.
Garg S, Gruppuso PA, Dumenco L Medicine and health, Rhode Island 2007 Sep 90 9 272-4
Predictors of depressed left ventricular function in patients presenting with ST-elevation myocardial infarction.
Bhave PD, Hoffmayer KS, Armstrong EJ, Garg S, Patel A, Macgregor JS, Stein JC, Kinlay S, Ganz P, McCabe JM The American journal of cardiology 2012 Feb 109 3 327-31
Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention–capable centers: a report from the Activate-SF registry.
McCabe JM, Armstrong EJ, Kulkarni A, Hoffmayer KS, Bhave PD, Garg S, Patel A, MacGregor JS, Hsue P, Stein JC, Kinlay S, Ganz P Archives of internal medicine 2012 Jun 172 11 864-71
In-hospital cardiopulmonary arrests in patients with left ventricular assist devices.
Garg S, Ayers CR, Fitzsimmons C, Meyer D, Peltz M, Bethea B, Cornwell W, Araj F, Thibodeau J, Drazner MH Journal of cardiac failure 2014 Dec 20 12 899-904
Human ventricular unloading induces cardiomyocyte proliferation.
Canseco DC, Kimura W, Garg S, Mukherjee S, Bhattacharya S, Abdisalaam S, Das S, Asaithamby A, Mammen PP, Sadek HA Journal of the American College of Cardiology 2015 Mar 65 9 892-900
Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension: Systematic Review and Meta-Analysis.
Pandey A, Garg S, Khunger M, Garg S, Kumbhani DJ, Chin KM, Berry JD Circulation. Heart failure 2015 Nov 8 6 1032-43
Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population.
Garg S, de Lemos JA, Ayers C, Khouri MG, Pandey A, Berry JD, Peshock RM, Drazner MH JACC. Cardiovascular imaging 2015 Sep 8 9 1034-41
Refining the classification of left ventricular hypertrophy to provide new insights into the progression from hypertension to heart failure.
Garg S, Drazner MH Current opinion in cardiology 2016 Jul 31 4 387-93
- Redesigning the medical science curriculum at the Warren Alpert Medical School of Brown University.
- Left Ventricular Remodeling
- Left Ventricular Assist Devices
- Heart Transplantation and Rejection
- Dilated Cardiomyopathy
- Advanced Heart Failure
- Heart Failure & Cardiac Support
- Heart Transplant